cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation
Clinical trial NCT04413656 · UNKNOWN
Trial details
- NCT number
- NCT04413656
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2020-12-17
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.